Clinical trial condition

ALL

Explore clinical trials studying ALL. Study availability and eligibility vary by location and protocol.

38 public trials 10 recruiting studies

Refine in advanced search Browse all conditions

ALL trial results

Completed

POETIC Plerixafor as a Chemosensitizing Agent for Relapsed Acute Leukemia and MDS in Pediatric Patients

NCT01319864

Conditions: ALL, AML, Acute Leukemia of Ambiguous Lineage, +20 more
Locations: Phoenix Children's Hospital Phoenix, Arizona, United States

The Children's Hospital of Denver Denver, Colorado, United States

Children's Healthcare of Atlanta/Emory University Atlanta, Georgia, United States

Johns Hopkins Medical Center Baltimore, Maryland, United States

View Trial Details

Completed

Understanding Methotrexate Induced Gastrointestinal Intolerance in Juvenile Idiopathic Arthritis and Childhood Leukemia

NCT02528435

Conditions: ALL, Arthritis, Arthritis, Juvenile, +8 more
Locations: Not specified

View Trial Details

Completed

Low Dose IL-2, Hematopoietic Stem Cell Transplantation, IL2 for GVHD

NCT00539695

Conditions: ALL, AML, Acute Lymphoblastic Leukemia, +31 more
Locations: Texas Children's Hospital Houston, Texas, United States

The Methodist Hospital Houston, Texas, United States

View Trial Details

Completed

Allogeneic Stem Cell Transplant With Clofarabine, Busulfan and Antithymocyte Globulin (ATG) for Adult Patients With High-risk Acute Myeloid Leukemia/Myelodysplastic Syndromes (AML/MDS) or Acute Lymphoblastic Leukemia (ALL)

NCT00863148

Conditions: ALL, AML, BAL, +1 more
Locations: Hôpital Edouard Herriot Lyon, France

Institut Paoli Calmettes Marseille, France

Nantes University hospital Nantes, France

Hôpital Saint Louis Paris, France

View Trial Details

Completed

Nonmyeloablative Allo SCT for the Treatment of Hematologic Disorders

NCT00636909

Conditions: ALL, AML, Anemia, +40 more
Locations: Not specified

View Trial Details

Completed

Testing the Re-Engineered Hospital Discharge

NCT00252057

Conditions: ALL, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: Boston Medical center Boston, Massachusetts, United States

View Trial Details

Completed

Umbilical Cord Blood Transplant for Hematological Malignancies

NCT00891592

Conditions: ALL, AML, Blood Protein Disorders, +21 more
Locations: University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Nonmyeloablative Allogeneic Stem Cell Transplantation From HLA-Matched Unrelated Donor for the Treatment of Hematologic Disorders

NCT00533923

Conditions: ALL, AML, Anemia, +34 more
Locations: Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

View Trial Details

Completed

Phase 1 Study of TG02 Citrate in Patients With Advanced Hematological Malignancies

NCT01204164

Conditions: ALL, AML, Blast Crisis, +28 more
Locations: RMCC Denver, Colorado, United States

Emory Atlanta, Georgia, United States

Rush Chicago, Illinois, United States

IU Indianapolis, Indiana, United States

View Trial Details

Completed

Photochemotherapy and Graft-versus-leukemia in Acute-leukemia

NCT02631993

Conditions: ALL, AML, Acute GVHD, +1 more
Locations: Department of Dermatology, Karolinska University Hospital Huddinge Stockholm, Stockholm County, Sweden

View Trial Details

ALL

ALL trial results

Related conditions